Thursday, October 20, 2022

Glenmark Pharma launches drug for diabetic patients with comorbidities

Glenmark Pharma launches drug for diabetic patients with comorbidities The Mumbai-based drug maker said it has become the first company to launch Teneligliptin (20mg) Dapagliflozin (5mg/10mg) fixed-dose combination for the treatment of adult patients with type 2 diabetes.

from Moneycontrol Business News https://ift.tt/tiBEHAq
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...